Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Aguado

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
ACS Infectious Diseases|May 16, 2024
Identification and Validation of Compounds Targeting <i>Leishmania major</i> Leucyl-Aminopeptidase M17Mirtha E Aguado, Sandra Carvalho, Mario E Valdés-Tresanco, et al.
Journal of Virological Methods|July 30, 2013
In vitro transcribed RNA molecules for the diagnosis of pandemic 2009 influenza A(H1N1) virus by real-time RT-PCRMario Bermúdez de León, Katia Peñuelas-Urquides, Miguel E Aguado-Barrera, et al.
Springerplus|February 3, 2016
Alcohol and breast cancer tumor subtypes in a Spanish CohortManuela Gago-Dominguez, J Esteban Castelao, Francisco Gude, et al.
Clinical Epigenetics|March 6, 2025
Epigenome-wide analysis reveals potential biomarkers for radiation-induced toxicity risk in prostate cancerCarlos Lopez-Pleguezuelos, Miguel E Aguado-Barrera, Ana Carballo-Castro, et al.
Clinical Chemistry|January 7, 2026
Splicing Predictions, Splicing Assays, and Variant Classification Using ACMG/AMP Guidelines: Challenges Observed with BRCA1 and BRCA2 VariantsMarta Santamariña, Olivia Fuentes-Ríos, Ana Blanco-Pérez, et al.
Journal of Clinical Virology Plus|August 29, 2022
Emergence and evolution of SARS-CoV-2 genetic variants during the Cuban epidemicMaría G Guzmán, Lissette Pérez, Yahisel Tejero, et al.
International Journal of Cancer|November 1, 2023
Reply to: Comments on "(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer"Juan C Rosas, Miguel E Aguado-Barrera, David Azria, et al.
International Journal of Cancer|July 5, 2023
(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancerJuan C Rosas, Miguel E Aguado-Barrera, David Azria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2026
Circadian genotypes in PER3 and time of prostate cancer radiotherapy interact to affect risk of late side-effectsAdam J Webb, Emily Harper, Tim Rattay, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2022
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE studyPhilipp Heumann, Miguel E Aguado-Barrera, Barbara Avuzzi, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
ACS Infectious Diseases|May 16, 2024
Identification and Validation of Compounds Targeting <i>Leishmania major</i> Leucyl-Aminopeptidase M17Mirtha E Aguado, Sandra Carvalho, Mario E Valdés-Tresanco, et al.
Journal of Virological Methods|July 30, 2013
In vitro transcribed RNA molecules for the diagnosis of pandemic 2009 influenza A(H1N1) virus by real-time RT-PCRMario Bermúdez de León, Katia Peñuelas-Urquides, Miguel E Aguado-Barrera, et al.
Springerplus|February 3, 2016
Alcohol and breast cancer tumor subtypes in a Spanish CohortManuela Gago-Dominguez, J Esteban Castelao, Francisco Gude, et al.
Clinical Epigenetics|March 6, 2025
Epigenome-wide analysis reveals potential biomarkers for radiation-induced toxicity risk in prostate cancerCarlos Lopez-Pleguezuelos, Miguel E Aguado-Barrera, Ana Carballo-Castro, et al.
Clinical Chemistry|January 7, 2026
Splicing Predictions, Splicing Assays, and Variant Classification Using ACMG/AMP Guidelines: Challenges Observed with BRCA1 and BRCA2 VariantsMarta Santamariña, Olivia Fuentes-Ríos, Ana Blanco-Pérez, et al.
Journal of Clinical Virology Plus|August 29, 2022
Emergence and evolution of SARS-CoV-2 genetic variants during the Cuban epidemicMaría G Guzmán, Lissette Pérez, Yahisel Tejero, et al.
International Journal of Cancer|November 1, 2023
Reply to: Comments on "(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer"Juan C Rosas, Miguel E Aguado-Barrera, David Azria, et al.
International Journal of Cancer|July 5, 2023
(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancerJuan C Rosas, Miguel E Aguado-Barrera, David Azria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2026
Circadian genotypes in PER3 and time of prostate cancer radiotherapy interact to affect risk of late side-effectsAdam J Webb, Emily Harper, Tim Rattay, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2022
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE studyPhilipp Heumann, Miguel E Aguado-Barrera, Barbara Avuzzi, et al.
Pageof 9